Decentralized Trials

Proven, flexible DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and industry-leading technologies that engage the right patients wherever they are. Our onsite and community-based solutions deliver flexible patient and site strategies for every therapeutic area. With over 500 active decentralized clinical trials (DCT) underway, across more than 75 countries and 30+ indications, IQVIA has the experience, capabilities and reach to meet any sponsor's needs.

Scalable. Validated. Patient Centric.

Nearly two-thirds of industry experts ranked IQVIA as the leader among decentralized trial solutions – more than any other technology or service provider.1 Our tested DCT model leverages technology and specialized services to engage participants within the community, and facilitate patient centric care including pre-screening, telemedicine visits, at-home treatment, or mobile research nurses and staff services.

Built on a foundation of global clinical operations capabilities and privacy compliance expertise, IQVIA Decentralized Trials is the first service provider to receive GDPR compliance validation from TRUSTArc, marking the first instance of a DCT service receiving this European data privacy validation.2

1Industry Standard Research, 2021

2IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation, 2022

Flexible DCT technology to boost study performance

IQVIA Decentralized Trials Platform helps sponsors deploy adaptable, patient-centric DCT technology for trials of all sizes, customized to fit any study and any indication – anywhere on the globe.

Available in dozens of languages, our end-to-end DCT platform expands traditional site boundaries to deliver a more efficient, more personalized experience without compromising the precision and rigor of the trial.

IQVIA’s DCT platform empowers patients across the globe with a concierge digital experience, including: text reminders, alerts, live chat, 24/7 support, and a scheduling tool to confirm or reschedule study visits.

Related solutions

Contact Us